Wed, Apr 26, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing Weekly

Defined benefit plans prefer hedge funds: hedge fund news, week 07

Saturday, February 08, 2014

In the week ending 07 February, 2014, hedge funds outperformed the S&P500 in January this year said Bank of America Merrill Lynch. Bridgewater Associates’ Ray Dalio gained 1.1% while David Einhorn’s Greenlight RE was down 1.5% in January, and Dan Loeb’s Third Point dropped 1.8% during the same period; Bill Ackman’s Pershing Square gained 4% last month to beat S&P 500.

GAM’s monthly insight said that hedge funds failed to realize their monthly expectations because of weak emerging market; Citadel defied the market slump in January as its two flagship funds rose 3.4%; Goldfinch Capital gained nearly 21% last month betting on natural gas; Och-Ziff Capital reported a sharply higher quarterly profit that beat Wall Street analysts' forecasts; and Andrew Hall’s Astenbeck commodity hedge fund lost 8.3% in 2013.

Ex-Deutsche Bank mortgage trader Troy Dixon said he would launch a $200m hedge fund; Capri Capital Partners plans to raise $400m to launch its first India-dedicated real estate private equity fund; Matthieu Bosser launched a commodity long/short fund that will bet on end of secular bull market; and Arden Asset will offer a second fund to allow the Main Street invest into hedge funds.

Omni launched the Omni Secured Lending Fund focused on secured property lending market in the UK; Gottex Fund launched a Swedish multi-asset UCITs product on Folksam unit linked platform; and Bermudan reinsurer Swan Re launched a hedge fund reinsurer.

Exis Capital said it would shut down following poor performance last year.

The......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Investing - How Chipotle's comeback attracted big data robots and value investors alike[more]

    From Forbes.com: When William Ackman's ailing hedge fund Pershing Square Capital Management bet $1 billion on shares in Chipotle Mexican Grill beginning in July 2016, the stakes couldn't have been higher. Pershing Square was reeling from what would eventually be a near $4 billion loss in drugmaker V